| Target Price | $402.90 |
| Price | $343.30 |
| Potential |
17.36%
register free of charge
|
| Number of Estimates | 23 |
|
23 Analysts have issued a price target Elevance Health 2026 .
The average Elevance Health target price is $402.90.
This is
17.36%
register free of charge
$516.02
50.31%
register free of charge
$299.97
12.62%
register free of charge
|
|
| A rating was issued by 28 analysts: 16 Analysts recommend Elevance Health to buy, 12 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Elevance Health stock has an average upside potential 2026 of
17.36%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 176.81 | 200.18 |
| 3.19% | 13.22% | |
| EBITDA Margin | 5.51% | 5.28% |
| 9.12% | 4.11% | |
| Net Margin | 3.38% | 3.36% |
| 3.21% | 0.66% |
22 Analysts have issued a sales forecast Elevance Health 2025 . The average Elevance Health sales estimate is
This results in the following potential growth metrics:
16 Analysts have issued an Elevance Health EBITDA forecast 2025. The average Elevance Health EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
25 Elevance Health Analysts have issued a net profit forecast 2025. The average Elevance Health net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 25.68 | 30.29 |
| 1.82% | 17.95% | |
| P/E | 11.34 | |
| EV/Sales | 0.50 |
25 Analysts have issued a Elevance Health forecast for earnings per share. The average Elevance Health EPS is
This results in the following potential growth metrics and future valuations:
Elevance Health...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Deutsche Bank |
Locked
➜
Locked
|
Locked | Dec 19 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Dec 18 2025 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Nov 26 2025 |
| Mizuho |
Locked
➜
Locked
|
Locked | Nov 04 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Oct 28 2025 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Oct 23 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Oct 22 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Deutsche Bank:
Locked
➜
Locked
|
Dec 19 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Dec 18 2025 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Nov 26 2025 |
|
Locked
Mizuho:
Locked
➜
Locked
|
Nov 04 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Oct 28 2025 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Oct 23 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Oct 22 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


